The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
FDA grants accelerated approval to glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas
The Food and Drug Administration has granted accelerated approval to glofitamab-gxbm for relapsed or refractory…